Work

Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis

Year: 2015

Type: article

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2015.11.001

Authors: Marissa D. Friedman, Mario Lacouture, Chau Dang

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2265478663

FWCI: 0.13

Cites: 31

Cited by: 10

Related to: 10